Skip to main content
. 2019 Mar 13;37(13):1120–1129. doi: 10.1200/JCO.18.01731

FIG 1.

FIG 1.

Kaplan-Meier plots of (A) progression-free survival (PFS) and (B) overall survival (OS) by Johns Hopkins University circulating tumor cell androgen receptor splice variant 7 (AR-V7) detection criteria and of (C) PFS and (D) OS by Epic Sciences circulating tumor cell AR-V7 detection criteria.